SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-12-144062
Filing Date
2012-03-30
Accepted
2012-03-30 17:26:29
Documents
10
Period of Report
2012-02-29

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d291174d10q.htm 10-Q 319605
2 CERTIFICATION OF CHIEF EXECUTIVE OFFICER PURSUANT TO RULE 13A-14(A) d291174dex311.htm EX-31.1 9638
3 CERTIFICATION OF CHIEF FINANCIAL OFFICER PURSUANT TO RULE 13A - 14(A) d291174dex312.htm EX-31.2 9691
4 CERTIFICATION PURSUANT TO 18 U.S.C. SECTIONS 1350 d291174dex32.htm EX-32 4981
  Complete submission text file 0001193125-12-144062.txt   2479011

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT neog-20120229.xml EX-101.INS 288733
6 XBRL TAXONOMY EXTENSION SCHEMA neog-20120229.xsd EX-101.SCH 20529
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE neog-20120229_cal.xml EX-101.CAL 40720
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE neog-20120229_def.xml EX-101.DEF 40252
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE neog-20120229_lab.xml EX-101.LAB 218595
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE neog-20120229_pre.xml EX-101.PRE 149142
Mailing Address 620 LESHER PLACE LANSING MI 48912
Business Address 620 LESHER PLACE LANSING MI 48912 5173729200
NEOGEN CORP (Filer) CIK: 0000711377 (see all company filings)

IRS No.: 382367843 | State of Incorp.: MI | Fiscal Year End: 0531
Type: 10-Q | Act: 34 | File No.: 000-17988 | Film No.: 12730500
SIC: 2835 In Vitro & In Vivo Diagnostic Substances